KARINA HOOPER: Open Payments
NPI 1538105069 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 65 payments from 13 companies in 2025. Trend: 2023 $794 · 2024 $923 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $428 |
| Aimmune Therapeutics, Inc. | 14 | $207 |
| Janssen Biotech, Inc. | 9 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| PFIZER INC. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 5 | $63 |
| VIVUS LLC | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $49 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
Products named: ZENPEP, RINVOQ, TREMFYA, SKYRIZI, XIFAXAN, VELSIPITY, LINZESS, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
